Description

Cayman has developed a SARS-CoV-2 Screening Library in which over 70,000 unique drugs and small molecules have been screened in silico for binding to SARS-CoV-2 targets including the spike glycoprotein, proteases, and non-structural proteins (nsps), and human angiotensin-converting enzyme 2 (ACE2). These are available as both a data pack and a library of the chemical entities in a 96-well format.

SARS-CoV-2 Screening Library
The SARS-CoV-2 Screening Library is a custom, made-to-order library that features a diverse set of FDA-approved and drug-like compounds identified from in silico modelling using Maestro (Schrödinger Suite) software. Choose from the entire library of 2,000+ compounds or a custom-built library to your preferred target and specifications.

SARS-CoV-2 Screening Data Package
The SARS-CoV-2 Library Data Package includes compound characteristics, docking scores (per target), and predicted physicochemical properties for ten SARS-CoV-2 targets.

Item	SARS-CoV-2 Targeted Libraries
Company	Cayman Chemical
Price	Get QuoteGet Quote
Catalog Number	Custom